China (Mainland)
Noopept CAS NO.157115-85-0
- Min.Order: 10 Gram
- Payment Terms: L/C,T/T,
- Product Details
Keywords
- Noopept
- 157115-85-0
- N-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester
Quick Details
- ProName: Noopept
- CasNo: 157115-85-0
- Appearance: white powder
- Application: for pharmaceutical usage
- DeliveryTime: within 3 days after payment
- PackAge: 25kg/drum
- Port: Shanghai,Guangzhou, Hongkong
- ProductionCapacity: 1 Metric Ton/Month
- Purity: >99%
- Storage: Kept in a cool, dry and ventilated pla...
- Transportation: by air; by sea; by express
- LimitNum: 10 Gram
- Related Substances: <0.1%
- Residue on Ignition: <0.5%
- Heavy Metal: <0.002%
- Valid Period: 2 years
Superiority
Hengxun pharmaceutical is a leading manufacturer and supplier of chemicals in China. We develop, produce and distribute high quality pharmaceuticals, intermediates, special chemicals and other fine chemicals.
We could give you:
1.Best quality in your requirement
2.Competitive price in China market
3.mature Technical support
4.Professional logistic support
All we want is win-win business. Send yr. inquiries, you will get it!
Details
Product Name: Noopept
Chemical Name: N-phenylacetyl-L-prolylglycine ethyl ester
CAS Number: 157115-85-0
Molecular Formula: C17H22N2O4
Molecular Weight: 318.37
Purity: 99.9% By HPLC
Appearance: A White powder
Noopept (Russian: Ноопепт; GVS-111, N-phenylacetyl-L-prolylglycine ethyl ester) is a medication promoted and prescribed in Russia and neighbouring countriesas a nootropic remedy. It is derived from the racetam family of drugs and shares similar mechanisms of action, but is up to 1000 times more potent than the prototypical racetam drug, piracetam. Animal studies have shown noopept to be neuroprotective and enhance memory in various different tests. Unusually for a peptide-derived compound, noopept displays both high oral bioavailability and good blood-brain barrier penetration, and human studies have shown promising results, with potential application in the treatment of Alzheimer's disease.